The -1082 A allele of the interleukin-10 single nucleotide polymorphism -1082 G/A is associated with hepatitis virus co-infection in Indonesian Javanese HIV patients

References

• Ranjbar R, Davari A, Izadi M, Jonaidi N, Alavian SM. HIV/HBV co-infections: epidemiology, natural history, and treatment: a review article. Iran Red Crescent Med J. 2011;13(12):855–862.
   PubMed Web of Science ®Google Scholar
• Andreoni M, Giacometti A, Maida I, Meraviglia P, Ripamonti D, Sarmati L. HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications. Eur Rev Med Pharmacol Sci. 2012;16(11):1473–1483.
   PubMed Web of Science ®Google Scholar
• Anggorowati N, Yano Y, Heriyanto DS, et al. Clinical and virological characteristic of hepatitis B or C virus co-infection with HIV in Indonesia patients. J Med Virol. 2013;84(6):857–865.
   Web of Science ®Google Scholar
• Prasetyo AA, Ariapramuda ER, Al Kindi E, et al. Men having sex with men in Surakarta, Indonesia: demographics, behavioral characteristics and prevalence of blood borne pathogens. Southeast Asian J Trop Med Public Health. 2014;45(5):1032–1047.
   Web of Science ®Google Scholar
• Prasetyo AA, Dirgahayu P, Sari Y, Hudiyono H, Kageyama S. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Java prisons, Indonesia. J Infect Dev Ctries. 2013;7(6):453–467.
   Web of Science ®Google Scholar
• Utsumi T, Yano Y, Lusida MI, et al. Detection of highly prevalent hepatitis B virus co-infection with HIV in Indonesia. Hepatol Res. 2013;43(10):1032–1039.
   PubMed Web of Science ®Google Scholar
• Wilson E, Brooks D. The role of IL-10 in regulating immunity to persistent viral infections. Curr Top Microbiol Immunol. 2011;350:39–65.
   PubMed Web of Science ®Google Scholar
• Brockman MA, Kwon DS, Tighe DP, et al. IL-10 is upregulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood. 2009;114(2):346–356.
   Web of Science ®Google Scholar
• Brooks DG, Walsh KB, Elsaesser H, Oldstone MB. IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection. Proc Natl Acad Sci U S A. 2010;107:3018–3023.
   PubMed Web of Science ®Google Scholar
• Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Höhler T. Differential regulation of interleukin-10 production by genetic and environmental factors – a twin study. Genes Immun. 2002;3(7):407–413.
   Web of Science ®Google Scholar
• Mörmann M, Rieth H, Hua TD, et al. Mosaics of gene variations in the Interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used. Genes Immun. 2004;5(4):246–255.
   Web of Science ®Google Scholar
• Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hitchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24(1):1–8.
   PubMedGoogle Scholar
• Erikstrup C, Kallestrup P, Zinyama-Gutsire RB, et al. Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults. AIDS. 2007;21(17):2283–2291.
   Web of Science ®Google Scholar
• Shin HD, Winkler C, Stephens JC, et al. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL-10. Proc Natl Acad Sci U S A. 2000;97(26):14467–14472.
   Web of Science ®Google Scholar
• Naicker DD, Werner L. Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. J Infect Dis. 2009;400(3):448–452.
   Google Scholar
• Chuang JY, Yang SS, Lu YT, et al. IL-10 promoter polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients. Dig Liver Dis. 2009;41(6):424–430.
   Google Scholar
• Migita K, Miyazoe S, Maeda Y, et al. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection – association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol. 2005;42(4):505–510.
   PubMed Web of Science ®Google Scholar
• Paladino N, Fainboim H, Theiler G, et al. Gender susceptibility to chronic hepatitis C virus infection associated with Interleukin 10 promoter polymorphism. J Virol. 2006;80(18):9144–9150.
   PubMed Web of Science ®Google Scholar
• Pár A, Pár G, Tornai I, et al. IL28B and IL-10R -1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort. BMC Res Notes. 2014;7:12.
   Google Scholar
• Truelove A, Oleksyk T. Evaluation of IL-10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. Int J Immunogenet. 2008;35(3):255–264.
   Web of Science ®Google Scholar
• Wang S, Huang D, Sun S, Ma W, Zhen Q. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfa. Virol J. 2011;8(1):28.
   Google Scholar
• Korachi M, Pravica V, Barson AJ, Hutchinson IV, Drucker DB. Interleukin 10 genotype as a risk factor for sudden infant death syndrome: determination of IL-10 genotype from wax-embedded postmortem samples. FEMS Immunol Med Microbiol. 2004;41(1):125–129.
   Google Scholar
• Kingkeow D, McNicholl JM, Maneekarn N, Wongtrakul J. Frequencies of IL-10 SNP genotypes by multiplex PCR-SSP and their association with viral load and CD4 counts in HIV-1-infected Thais. Asian Pac J Allergy Immunol. 2011;29(1):94–101.
   Web of Science ®Google Scholar
• Naicker DD, Wang B, Losina E, et al. Association of IL-10-promoter genetic variants with the rate of CD4 T-cell loss, IL-10 plasma levels, and breadth of cytotoxic T-cell lymphocyte response during chronic HIV-1 infection. Clin Infect Dis. 2012;54(2):294–302.
   Web of Science ®Google Scholar
• Talaat RM, Ashour ME, Bassyouni IH, Raouf AA. Polymorphisms of interleukin 6 and interleukin 10 in Egyptian people with Behcet’s disease. Immunobiology. 2014;219(8):573–582.
   PubMed Web of Science ®Google Scholar
• Dolganiuc A, Chang S, Kodys K, et al. Hepatitis C virus (HCV) Core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J Immunol. 2006;177(10):6758–6768.
   PubMed Web of Science ®Google Scholar
• Dolganiuc A, Kodys K, Kopasz A, et al. Hepatitis C Virus Core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol. 2003;170(110):5615–5624.
   Google Scholar
• Villacres MC, Kono N, Mack WJ, et al. Interleukin 10 responses are associated with sustained CD4 T cell counts in treated HIV infection. J Infect Dis. 2012;206(5):780–789.
   Web of Science ®Google Scholar
• Talaat RM, Dondeti MF, El-Shenawy SZ, Khamiss OA. Association between IL-10 gene promoter polymorphism and hepatitis B viral infection in an Egyptian population. Biochem Genet. 2014;52(9–10):387–402.
   PubMed Web of Science ®Google Scholar
• Lu YL, Wu X, Huang HL, Dai LC. Allele polymorphisms of interleukin-10 and hepatitis B, C virus infection. Chin Med J (Engl). 2010;123(10):1338–1344.
   Web of Science ®Google Scholar
• Zhang TC, Pan FM, Zhang LZ, et al. A meta-analysis of the relation of polymorphism at sites -1082 and -592 of the IL-10 gene promoter with susceptibility and clearance to persistent hepatitis B virus infection in the Chinese population. Infection. 2011;39(1):21–27.
   Web of Science ®Google Scholar
• Shin HD. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet. 2003;12(8):901–906.
   Web of Science ®Google Scholar
• Gao QJ, Liu DW, Zhang SY, et al. Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol. 2009;15(44):5610–5619.
   Web of Science ®Google Scholar
• Ishida C, Ikebuchi Y, Okamoto K, Murawaki Y. Functional gene polymorphisms of interleukin-10 are associated with liver disease progression in Japanese patients with hepatitis C virus infection. Intern Med. 2011;50(7):659–666.
   Web of Science ®Google Scholar